← Back to cartilage injury
Cartilage injury · Evidence review

Cartilage repair: comparing the options

Cartilage does not heal on its own. When a damaged area is causing pain and swelling, there are four main ways to repair it, each with different strengths. The right choice depends mostly on the size and depth of the damage, where it is in the knee, your age, and how active you are. This page compares the options using the research that puts them head to head.

The four options

Marrow stimulation
Microfracture
Small holes are made in the bone under the defect. Blood and marrow cells fill the area and form a scar-like repair tissue called fibrocartilage.
Best for
Small defects, under about 2 cm², in lower-demand patients. A single, arthroscopic, lower-cost procedure.
The repair tissue is softer than normal cartilage and tends to wear down over time, especially in athletes.1,2
Your own tissue
OATS autograft
Plugs of healthy cartilage and bone are moved from a low-load part of your own knee into the defect, restoring true cartilage in one operation.
Best for
Small defects, generally up to about 2 cm², in young athletes, including defects that involve the bone.
Lower failure and higher return to sport than microfracture.1,2,3 Only a limited amount of donor cartilage can be taken from the knee, so it is reserved for small defects.
Donor tissue
OATS allograft
A matched piece of fresh donor cartilage and bone is shaped to fill the defect, also in one operation.
Best for
Large defects, defects with bone loss, and revision after other repairs have failed.
About 78% of grafts survive at 10 years.5,6 Depends on donor availability.
Your own cells
MACI
Cartilage cells are taken from your knee in a first, small arthroscopic surgery, grown in a lab, and implanted on a membrane in a second surgery.
Best for
Medium to large surface defects, about 2 to 10 cm², without much bone loss, including the kneecap.
Better pain and function than microfracture at 5 years for defects 3 cm² or larger.7,8 Two surgeries and a longer rehab.
Head to head

How they compare

Microfracture
OATS autograft
OATS allograft
MACI
Repair tissue
Fibrocartilage (scar-like)
Your own true cartilage
Donor true cartilage
Cartilage-like tissue from your own cells
Defect size
Small
Small (up to about 2 cm²)
Large, or with bone loss
Medium to large
Surgeries
One
One
One
Two
Failure
38% at 10 years in athletes1
14% at 10 years in athletes1
~22% at 10 years5,6
Fewer failures than microfracture at 5 years8
Return to sport
Lower and less durable1,3
86–100% at long-term follow-up4
75–82%9
Good in active patients8
Microfracture vs OATS

What the trials show

14% vs 38%
Failure at 10 years, OATS autograft vs microfracture, in a randomized trial of young athletes.1

In the only randomized trial that followed young athletes for 10 years, OATS had better scores and far fewer failures than microfracture, and MRI showed better filling of the defect.1 A meta-analysis of randomized trials found that patients who had OATS returned to sport sooner and more often, including to their pre-injury level.3 Microfracture often works well for the first year or two, then tends to decline after a few years in active patients.2

The difference is smaller in less active people. In a randomized trial of a mixed, not mainly athletic group followed for nearly 10 years, there was no significant difference between the two.10

MACI vs microfracture

The SUMMIT trial

The SUMMIT randomized trial compared MACI with microfracture in 144 patients with defects of 3 cm² or larger.7 At 2 years, MACI gave significantly better pain and function scores, and that advantage was maintained at 5 years.7,8 Both treatments improved the defect filling on MRI, without a significant difference between them.8

3 cm²+
Defect size where MACI outperformed microfracture.7
5 years
Better pain and function with MACI maintained through 5 years.8

Osteochondral allograft

Results for large defects

78%
Graft survival at 10 years in a large single-center study.5
87% / 79%
Average graft survival at 5 and 10 years across 19 studies.6
90%
Chance of surviving to 10 years for grafts still in place at 4 years.5

Most allograft failures happen in the first 3 years. After that, the yearly failure rate drops to about 1.5%.5 Revision cases, kneecap defects, and defects on both sides of the joint have lower survival.6 Allografts still work well after a failed microfracture, so an earlier microfracture does not rule this option out.11 Further procedures are common, often a small arthroscopy to remove loose tissue.9

Choosing the right repair

How we decide together

We look at the size and depth of the defect, where it is, whether the bone is involved, your alignment, your age, and your goals. Problems that overload the cartilage, such as malalignment, an unstable kneecap, a torn ACL, or a missing meniscus, need to be corrected at the same time, or the repair is less likely to last.

References

  1. 1Gudas R, Gudaite A, Pocius A, et al. Ten-year follow-up of a prospective, randomized clinical study of mosaic osteochondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint of athletes. Am J Sports Med. 2012;40(11):2499–2508. Link →
  2. 2Pareek A, Reardon PJ, Macalena JA, et al. Osteochondral autograft transfer versus microfracture in the knee: a meta-analysis of prospective comparative studies at midterm. Arthroscopy. 2016;32(10):2118–2130. Link →
  3. 3Comparative efficacy of osteochondral autologous transplantation and microfracture in the knee: an updated meta-analysis of randomized controlled trials. Arch Orthop Trauma Surg. 2021. Link →
  4. 4Autologous osteochondral transfer of the knee demonstrates continued high rates of return to sport and low rates of conversion to arthroplasty at long-term follow-up: a systematic review. Arthroscopy. 2023. Link →
  5. 5Linstrom NW, Bugbee WD, Wang T. Conditional survivorship of osteochondral allograft transplantation in the knee. Orthop J Sports Med. 2026;14(8). Link →
  6. 6Familiari F, Cinque ME, Chahla J, et al. Clinical outcomes and failure rates of osteochondral allograft transplantation in the knee: a systematic review. Am J Sports Med. 2018. Link →
  7. 7Saris D, Price A, Widuchowski W, et al. Matrix-applied characterized autologous cultured chondrocytes versus microfracture: two-year follow-up of a prospective randomized trial (SUMMIT). Am J Sports Med. 2014;42(6):1384–1394. Link →
  8. 8Brittberg M, Recker D, Ilgenfritz J, Saris DBF; SUMMIT Extension Study Group. Matrix-applied characterized autologous cultured chondrocytes versus microfracture: five-year follow-up of a prospective randomized trial. Am J Sports Med. 2018. Link →
  9. 9Return to sport and sports-specific outcomes after osteochondral allograft transplantation in the knee: a systematic review of studies with at least 2 years’ mean follow-up. Arthroscopy. 2019. Link →
  10. 10Ulstein S, Årøen A, Røtterud JH, et al. Microfracture technique versus osteochondral autologous transplantation mosaicplasty in patients with articular chondral lesions of the knee: a prospective randomized trial with long-term follow-up. Knee Surg Sports Traumatol Arthrosc. 2014. Link →
  11. 11Gracitelli GC, Meric G, Briggs DT, et al. Fresh osteochondral allografts in the knee: comparison of primary transplantation versus transplantation after failure of previous subchondral marrow stimulation. Am J Sports Med. 2015;43(4):885–891. Link →

This page summarizes published research for patient education. Study results describe groups of patients and may not apply to you. It is not a substitute for an evaluation and a discussion of your own knee.

Kevin Jiang, MD
Orthopaedic Surgery · Sports Medicine
English · Mandarin · Spanish
Accepting new patients
Locations
72-06 Northern Blvd, 2nd Fl
Jackson Heights, NY 11372

2825 Jackson Ave
Long Island City, NY 11101

(866) 670-6824
Fax: (718) 533-1770
Where surgery happens
NewYork-Presbyterian Queens
56-45 Main Street, 4th Fl South
Flushing, NY 11355
(718) 670-2558
Hospital affiliations: NewYork-Presbyterian Queens; NewYork-Presbyterian / Columbia University Irving Medical Center; Hospital for Special Surgery (Affiliate Medical Staff). Institutional names denote affiliation, not endorsement.
This site is for informational purposes only and does not constitute medical advice. Use of this site does not create a doctor-patient relationship. For emergencies call 911.
© 2026 Kevin Jiang, MD